Lung Cancer 1.Tilelizumab’s second-line or third-line treatment of non-small cell lung cancer Phase III RATIONALE 303 trial reached its primary clinical endpoint. On November 17, BeiGene announced the interim analysis […]
1.Cell Rep: Uncovering the new molecular mechanism of tumor suppressor p53-induced cancer cell death doi: 10.1016 / j.celrep.2020.03.011 There has been an ongoing battle between cancer cells and p53. P53 is […]
PLoS Biol: Scientists reveal new mechanism of Rapamycin. doi: 10.1371 / journal.pbio.3000252 Recently, in a research report published in PLoS Biology, scientists from the University of Michigan revealed a new […]
P53 is a well-known human anticancer protein, known as the guardian of the human genome. Wild-type p53 (WTp53) are widely found in nature. Recently, scientists from the University of California found […]
Introduction P53 tumor suppressor gene is a kind of gene that inhibits cells from transforming into cancer cells in living organisms. There are oncogene and tumor suppressor gene in the […]
Toll-like receptors (TLRs) are a class of proteins plays an important role in the natural immune system receptor, it was found in the 1990s, a typical pattern recognition receptor (PRR), […]
Scientists have successfully found a way for producing an important cancer drug ingredient in lab recently, which may bring a decrease to the cost of the related drug as its […]